1,509
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Instrumental and Technical Evolution Over the Past Decade in Bioanalysis

Pages 601-606 | Received 31 Dec 2018, Accepted 22 Feb 2019, Published online: 04 Apr 2019

References

  • Barfield M , SpoonerN, LadR, ParryS, FowlesS. Application of dried blood spots combined with HPLC–MS/MS for the quantification of acetaminophen in toxicokinetic studies. J. Chromatogr. B870 (1), 32–37 (2008).
  • Spooner N , LadR, BarfieldM. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: consideration for the validation of a quantitative bioanalytical method. Anal. Chem. B81 (4), 1557–1563 (2009).
  • Meesters RJ , HooffGP. State-of-the-art dried blood spot analysis: an overview of recent advances and future trends. Bioanalysis5 (17), 2187–2208 (2013).
  • Zimmer JS , ChristiansonCD, JohnsonCJ, NeedhamSR. Recent advances in the bioanalytical applications of dried matrix spotting for the analysis of drugs and their metabolites. Bioanalysis5 (20), 2581–2588 (2013).
  • De Kesel PM , SadonesN, CapiauS, LambertWE, StoveCP. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis2 (8), 1415–1422 (2010).
  • D'Arienzo CJ , JiQC, DiscenzaLet al. DBS sampling can be used to stabilize prodrugs in drug discovery rodent studies without the addition of esterase inhibitors. Bioanalysis2 (8), 1415–1422 (2010).
  • Meesters RJ , HooffGP, GrutersR, Van KampenJJ, LuiderTM. Incurred sample reanalysis comparison of dried blood spots and plasma samples on the measurement of lopinavir in clinical samples. Bioanalysis4 (3), 237–240 (2012).
  • Turpin PE , BurnettJE, GoodwinL, FosterA, BarfieldM. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories. Bioanalysis2 (8), 1489–1499 (2010).
  • Denniff P , SpoonerN. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis2 (8), 1385–1395 (2010).
  • Zimmer D , HasslerS, BetschartB, SackS, FankhauserC, LoppacherM. Internal standard application to dried blood spots by spraying: investigation of the internal standard distribution. Bioanalysis5 (6), 711–719 (2013).
  • Burnett JE . Dried blood spot sampling: practical considerations and recommendation for use in preclinical studies. Bioanalysis3 (10), 1099–1107 (2011).
  • Spooner N , RamakrishnanY, BarfieldM, DewitO, MillerS. Use of DBS sample collection to determine circulating blood concentrations in clinical trials: practicalities and considerations. Bioanalysis2 (8), 1515–1522 (2010).
  • Nilsson LB , AhnoffM, JonssonO. Capillary microsampling in the regulatory environment: validation and use of capillary microsampling methods. Bioanalysis5 (6), 731–738 (2013).
  • Jonsson O , Palma VillarR, NilssonLBet al. Capillary microsampling of 25 μl blood for the determination of toxicokinetic parameters in regulatory studies in animals. Bioanalysis4 (6), 661–674 (2012).
  • Jonsson O , VillarRP, NilssonLB, ErikssonM, KonigssonK. Validation of a bioanalytical method using capillary microsampling of 8 μl plasma samples: application to a toxicokinetic study in mice. Bioanalysis4 (16), 1989–1998 (2012).
  • Dillen L , LoomansT, Van de PerreG, VersweyveldD, WuytsK, de ZwartL. Blood microsampling using capillaries for drug–exposure determination in early preclinical studies: a beneficial strategy to reduce blood sample volumes. Bioanalysis6 (3), 293–306 (2014).
  • Needham S . Microspray and microflow liquid chromatography: the way forward for LC-MS bioanalysis. Bioanalysis9 (24), 1935–1937 (2017).
  • Lassman M , Fernandez-MetzlerC. Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&D. Bioanalysis6 (13), 1859–1867 (2014).
  • Arnold DW , NeedhamS. Micro-LC–MS/MS: the future of bioanalysis. Bioanalysis5 (11), 1329–1331 (2013).
  • Wang H , BennettP. Performance assessment of microflow LC combined with high-resolution MS in bioanalysis. Bioanalysis5 (10), 1249–1267 (2013).
  • Christianson C , JohnsonCJL, NeedhamSR. The advantages of microflow LC–MS/MS compared with conventional HPLC–MS/MS for the analysis of methotrexate from human plasma. Bioanalysis5 (11), 1387–1396 (2013).
  • Zhang Q , TomazelaD, VasicekLAet al. Automated DBS microsampling, microscale automation and microflow LC–MS for therapeutic protein PK. Bioanalysis8 (7), 649–659 (2016).
  • Chambers EE , LameME, RainvillePDet al. Quantitative bottom up analysis of infliximab in serum using protein A purification and integrated LC-electrospray chip IonKey MS/MS technology. Bioanalysis8 (9), 891–904 (2016).
  • Kleinnijenhuis A , IngolaM, ToerscheJ, van HolthoonF, van DongenW. Quantitative bottom up analysis of infliximab in serum using protein A purification and integrated LC-electrospray chip IonKey MS/MS technology. Bioanalysis8 (9), 891–904 (2016).
  • Saito M . History of supercritical fluid chromatography: instrumental development. J. Biosci. Bioeng.115, 590–599 (2013).
  • Desfontaine VJ , VeutheyL, GuillarmeD. Hyphenated detectors: mass spectrometry. In : Supercritical Fluid Chromatography. PooleC ( Ed.). Elsevier, Amsterdam, The Netherlands, 213–244 (2016).
  • Desfontaine V , NovakovaL. SFC-MS versus RPLC-MS for drug analysis in biological samples. Bioanalysis7 (10), 1193–1195 (2015).
  • Campbell JL , LeBlancJCY, KibbeyRG. Differential mobility spectrometry: a valuable technology for analyzing challenging biological samples. Bioanalysis7 (7), 853–856 (2015).
  • Xia YQ , CiccimaroE, ZhengN, ZhuM. Differential mobility spectrometry combined with multiple ion monitoring for bioanalysis of disulfide-bonded peptides with inefficient collision-induced dissociation fragmentation. Bioanalysis9 (2), 183–192 (2017).
  • Fu Y , XiaYQ, FlarakosJet al. Differential mobility spectrometry coupled with multiple ion monitoring in regulated LC–MS/MS bioanalysis of a therapeutic cyclic peptide in human plasma. Anal. Chem.88 (7), 3655–3661 (2016).
  • Beach DG , KerrinES, QuilliamMA. Selective quantitation of the neurotoxin BMAA by use of hydrophilic-interaction liquid chromatography–differential mobility spectrometry-tandem mass spectrometry (HILIC-DMS–MS/MS). Anal. Bioanal. Chem.407 (28), 8397–8409 (2015).
  • Ray JA , KushnirMM, YostRAet al. Performance enhancement in the measurement of 5 endogenous steroids by LC–MS/MS combined with differential ion mobility spectrometry. Clin. Chim. Acta438, 330–336 (2015).
  • Kyle JE , AlyN, ZhengX, Burnum-JohnsonET KE, SmithRD, BakerES. Evaluating lipid mediator structural complexity using ion mobility spectrometry combined with mass spectrometry. Bioanalysis10 (5), 279–289 (2018).
  • Metz OM , BakerES, SchymanskiELet al. Integrating ion mobility spectrometry into mass spectrometry-based exposome measurements: what can it add and how far can it go? Bioanalysis 9 (1), 81–98 (2017).
  • Tsai CW , YostRA, GarrettTJ. High-field asymmetric waveform ion mobility spectrometry with solvent vapor addition: a potential greener bioanalytical technique. Bioanalysis4 (11), 1363–1375 (2012).
  • Ramagiri S , GarofoloF. Large molecule bioanalysis using Q-TOF without predigestion and its data processing challenges. Bioanalysis4 (5), 529–540 (2012).
  • Manna JD , RichardsonSJ, MoghaddanMF. Implementation of a novel ultra fast metabolic stability analysis method using exact mass TOF-MS. Bioanalysis9 (4), 359–368 (2017).
  • Jiang J , JamesCJ, WongP. Determination of rosiglitazone and 5-hydroxy rosiglitazone in rat plasma using LC–HRMS by direct and indirect quantitative analysis. Bioanalysis5 (15), 1873–1881 (2013).
  • Morin L-P , MessJ-N, GarofoloF. Large-molecule quantification: sensitivity and selectivity head-to-head comparison of triple quadrupole with Q-TOF. Bioanalysis5 (10), 1181–1193 (2013).
  • Plumb RS , FujimotoG, MatherJet al. Comparison of the quantification of a therapeutic protein using nominal and accurate mass MS/MS. Bioanalysis4 (5), 605–615 (2012).
  • Dillen L , CoolsW, VereykenLet al. Comparison of triple quadrupole and high-resolution TOF-MS for quantification of peptides. Bioanalysis4 (5), 565–579 (2012).
  • Rochat B , PeduzziD, McMullenJet al. Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform. Bioanalysis5 (20), 2509–2520 (2013).
  • Mekhssian K , MessJ-N, GarofoloF. Application of high-resolution MS in the quantification of a therapeutic monoclonal antibody in human plasma. Bioanalysis6 (13), 1767–1779 (2014).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.